Two of China’s most strategically significant technology companies, memory chipmaker CXMT and humanoid robot maker Unitree, have cleared their STAR Market listing reviews, setting the stage for what analysts are calling the most consequential IPO wave on Shanghai’s tech-focused exchange since 2020, according to reporting by Nikkei Asia and the Wall Street Journal. The dual clearances signal not only investor confidence in China’s domestic AI supply chain, but also a deliberate regulatory push to fast-track funding for companies operating at the front lines of the US-China technology race.
CXMT Eyes the Second-Largest STAR Market Listing in History
Changxin Memory Technologies, better known as CXMT, is planning to raise ¥29.5 billion, approximately $4.35 billion, in what would be the second-largest listing on the STAR Market since its launch in 2019. The offering comes as China’s domestic memory chip sector faces both enormous tailwinds and persistent structural challenges.
CXMT has emerged as one of Beijing’s most important bets in the race to build a self-sufficient semiconductor industry. As US export controls on advanced chips have progressively tightened access to foreign memory technology, CXMT has been quietly scaling production of DRAM chips that would otherwise need to be sourced from Samsung, SK Hynix, or Micron. A successful IPO at this scale would provide the company with the capital necessary to accelerate process node development and expand manufacturing capacity at a critical moment.
The fundraise also reflects a broader structural shift in how China’s semiconductor champions are being financed. Rather than relying exclusively on state-backed venture funds or opaque private placements, CXMT’s path to the public markets represents a maturation of China’s chip funding ecosystem, one that increasingly looks to domestic retail and institutional investors to shoulder long-term capital commitments alongside government stakeholders.
Unitree’s Record 73-Day Review Signals Regulatory Intent
If CXMT’s listing represents the hardware backbone of China’s AI ambitions, Unitree’s clearance speaks to the country’s equally aggressive push in embodied intelligence. The Hangzhou-based humanoid robot maker cleared its STAR Market listing review in just 73 days, a record pace, and plans to raise ¥4.2 billion to fund its next phase of development.
Unitree has become one of the most globally recognized names in Chinese robotics, with its quadruped and humanoid platforms attracting attention far beyond domestic markets. The company’s rapid review timeline is particularly noteworthy given that both CXMT and Unitree were among the first companies to use a new “pre-review” confidential filing process introduced by the Shanghai Stock Exchange. That mechanism, designed to streamline the path to market for high-priority technology companies, appears to be operating exactly as regulators intended.
The humanoid robot sector in China has moved with extraordinary speed over the past 18 months. Unitree’s IPO ambitions place it alongside a cohort of well-capitalized rivals, including AGIBot, which earlier this year declared 2026 its “Year One” of deployment and unveiled five new robots alongside eight foundation models. AGIBot also made headlines when its A2 humanoid appeared at the Met Gala, demonstrating the global branding ambitions of China’s top-tier robotics firms. Unitree’s public listing would give it a comparable war chest to compete, and potentially surpass, on the international stage.
A STAR Market Running Hot on AI
The backdrop for both listings is a STAR Market that has surged more than 20% year-to-date, driven overwhelmingly by investor enthusiasm for AI-related equities. The index’s performance reflects a domestic technology rally that has been building since the global shockwave triggered by DeepSeek’s emergence earlier this year, which demonstrated that Chinese AI labs could achieve frontier-level results at a fraction of the cost Western competitors assumed.
That momentum has created a receptive environment for large technology IPOs that would have faced a far more skeptical market just two years ago. Capital that once flowed primarily into internet and consumer platforms is now being directed toward semiconductor manufacturers, robotics firms, and AI infrastructure providers — exactly the categories that CXMT and Unitree represent.
The listings also arrive at a moment when China’s AI commercialization story is increasingly moving from research labs into the real economy. AI applications are spreading from farms to factories across China, and the demand for the underlying hardware, memory chips, inference accelerators, robotic systems, is accelerating accordingly. CXMT’s DRAM is a foundational input for virtually every AI workload running inside China’s rapidly expanding data center fleet.
The Confidential Filing Process as a Policy Signal
Perhaps the most strategically meaningful element of these listings is the regulatory mechanism that enabled them. The new “pre-review” confidential filing process, which both CXMT and Unitree were the first to use, allows companies to engage with exchange regulators before making their filings public. This reduces the risk of competitive intelligence leakage during the review process, a concern that is particularly acute for a memory chipmaker operating in a sector under intense international scrutiny.
The introduction of this process reflects Beijing’s recognition that the standard IPO review timeline, which can stretch for years under the conventional approval system, is ill-suited for companies racing against foreign competitors in strategically vital sectors. By compressing Unitree’s review to 73 days, regulators have sent a clear signal: companies at the frontier of China’s technology priorities will receive an accelerated path to the capital markets.
This approach mirrors broader trends in how Chinese policymakers are aligning financial market infrastructure with industrial policy goals. The 9th Digital China Summit’s emphasis on AI innovation and its new 2026–2030 digital development plan underscored the government’s intention to use every available lever, including capital market reform, to sustain technological momentum.
Implications for Global Tech Competition
The combined fundraising target of CXMT and Unitree, approximately $5 billion at current exchange rates, would represent a substantial injection of growth capital into two sectors where China is actively challenging US dominance. CXMT’s memory ambitions sit directly in the crosshairs of American chip controls, while Unitree competes in a humanoid robotics market where Chinese firms are increasingly drawing global attention, as seen at Hannover Messe earlier this year.
For investors, the STAR Market’s current trajectory suggests that domestic confidence in China’s AI and hardware ecosystem remains high despite geopolitical headwinds. For policymakers in Washington and Brussels, two freshly capitalized Chinese champions in memory chips and humanoid robotics represent a tangible escalation of the long-term technology competition, one that balance sheets, not just export control lists, will ultimately shape.